described two distinct T-cell populations necessary for a functioning immune response against human cancer—one consisting of stem-like T cells (characterized by TCF7 expression) and one of more differentiated T cells (characterized by T-bet expression) [22]. The gene discussed is TCF7; the disease is cancer.